Time-series pioneers share Nobel Prize for Economics
Robert Engle, a finance professor at New York University, and Clive Granger, currently a visiting scholar at New Zealand’s Canterbury University, will share this year’s Nobel Prize for Economics. The recipients’ work on the analysis of time-series data has provided powerful mathematical tools for research in derivatives pricing, risk management and economics.
The Nobel Committee said Engle’s award recognises his role in devising “methods for analysing economic time series with varying volatility”, while Granger created “methods of analysing economic time series with common trends”.
Up until the mid-to-late-1980s, many risk managers, traders and academics largely assumed volatility was constant over time. The jettisoning of this flawed assumption in the interim is in no small way due to Engle’s work in the early 1980s, when he developed the concept of autoregressive heteroskedasticity (Arch). This statistical technique ushered in a new era of more realistic volatility modelling.
Engle will speak about a new correlation estimator for credit risk evaluation at Risk’s Credit Risk Summit Europe 2003, which will be held in London on October 21 and October 22. He has a long relationship with Risk, with some of his earlier volatility research appearing in the magazine - see ‘Garch for Groups’, Risk August 1996, page 36; and ‘Grappling with Garch’, Risk September 1995, page 112. Both technical papers were co-authored with Joseph Mezrich.
Granger’s research has been particularly useful in macroeconomic analysis. Most significantly, he discovered certain combinations of non-stationary time series exhibit stationarity - that is, the series fluctuates around a specific value. This result allows robust statistical inferences to be made, which shed new light on the relations between consumption and wealth, and short- and long-term interest rates, for example.
Engle and Granger will receive a total award of SKr10 million ($1.3 million).
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on Risk management
Op risk data: TD Bank takes US reg pill in purported drug-related AML fails
Also: SCB fraud bill rising fast; Postbank pain for Deutsche Bank. Data by ORX News
Clear warning on escape hatch for optimisation trades
CCPs fear Emir clearing mandate carve-out for portfolio rebalancing could be abused
One year on, regulators still want a cure for bank runs
Broad support for higher outflow assumptions on uninsured deposits, but that won’t save insolvent banks
Falling T2 balances bode well for eurozone’s stability
Impact of fragmentation would be less severe today than in 2010s, says Marcello Minenna
For a growing number of banks, synthetics are the real deal
More lenders want to use SRTs to offload credit risk, but old hands say they have a long road ahead
Did Fed’s stress capital buffer blunt CCAR?
Experts fear flagship test’s use as a capital top-up has undermined its role in risk management
How Ally found the key to GenAI at the bottom of a teacup
Risk-and-tech chemistry – plus Microsoft’s flexibility – has seen US lender leap from experiments to execution
Industry urges focus on initial margin instead of intraday VM
CPMI-Iosco says scheduled variation margin is better than ad hoc calls by clearing houses
Most read
- Breaking out of the cells: banks’ long goodbye to spreadsheets
- Too soon to say good riddance to banks’ public enemy number one
- Industry calls for major rethink of Basel III rules